4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-053371
Chief Business Development Off sold 6,771 shares at an average $48.57 ($328,837)
- Chief Business Development Off acquired 6,771 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise | +2,604 | $6.55 | $17,056 | 2,604 | D |
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise | +2,605 | $6.55 | $17,063 | 5,209 | D |
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise | +1,562 | $7.27 | $11,356 | 6,771 | D |
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Sale | −5,878 | $48.46 | $284,848 | 893 | D |
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Sale | −893 | $49.26 | $43,989 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise · Stock Option (Right to Buy) | −2,604 | 33,855 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise · Stock Option (Right to Buy) | −2,605 | 62,500 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-10-01 | Option exercise · Common Stock (Right to Buy) | −1,562 | 42,188 | D | ||
| Open-market sales · 6,771 sh · avg $48.57 · $328,837 | |||||||
Loading xslF345X03/doc4.xml…